Recently stock market analysts have updated their consensus ratings on shares of Applied DNA Sciences (APDN). The latest broker reports which are currently outstanding on Monday 9th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, 0 analysts “neutral”, 0 analysts “sell” and 0 analysts “strong sell”.

Most recent broker ratings

10/08/2015 – Applied DNA Sciences had its “buy” rating reiterated by analysts at Maxim Group. They now have a USD 13 price target on the stock.

05/26/2015 – Benchmark began new coverage on Applied DNA Sciences giving the company a “speculative buy” rating. They now have a USD 5 price target on the stock.

08/14/2014 – Applied DNA Sciences had its “outperform” rating reiterated by analysts at Zacks. They now have a USD 0.25 price target on the stock.

Applied DNA Sciences has a 50 day moving average of 3.19 and a 200 day moving average of 3.42. The stock’s market capitalization is 71.25M, it has a 52-week low of 2.30 and a 52-week high of 9.70.

The share price of the company (APDN) was up +1.37% during the last trading session, with a high of 2.99 and the volume of Applied DNA Sciences shares traded was 91831.

View other investors thoughts on Applied DNA Sciences on our new Stock Talk discussion platform. Sign up for free to contribute to the community and view research provided from other investors for any stock listed on the LSE, NYSE or NASDAQ.